Asambly Chemicals Co. Ltd.

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
News
Home ProductsTicagrelor Intermediates

CAS 155899 66 4 Ticagrelor Intermediates C8H15NO3 99.0% Min cGMP standard

I'm Online Chat Now

CAS 155899 66 4 Ticagrelor Intermediates C8H15NO3 99.0% Min cGMP standard

China CAS 155899 66 4 Ticagrelor Intermediates C8H15NO3 99.0% Min cGMP standard supplier

Large Image :  CAS 155899 66 4 Ticagrelor Intermediates C8H15NO3 99.0% Min cGMP standard

Product Details:

Place of Origin: China
Certification: Meet with cGMP standard

Payment & Shipping Terms:

Minimum Order Quantity: 1KG
Packaging Details: Drum
Contact Now
Detailed Product Description
Usage: Ticagrelor Intermediate CAS: 155899-66-4
Molecular Formula: C8H15NO3
High Light:

145783 14 8

,

1156491 10 9

CAS : 155899-66-4 Ticagrelor Intermediate C8H15NO3 99.0% min

 

Chemical Name : 4H - Cyclopenta - 1 , 3 - dioxol - 4 - ol , 6-aminotetrahydro - 2 , 2 - dimethyl - ,  ( 3aR , 4S , 6R , 6aS ) - 

 

CAS No . : 155899-66-4

 

Synonyms :  ( 3aR , 4S , 6R , 6aS ) - 6 - Aminotetrahydro - 2 , 2 - dimethyl - 4H - cyclopenta - 1 , 3 - dioxol - 4 - ol

 

Molecular Formula : C8H15NO3

 

Molecular Weight : 173.21

 

Usuage: Ticagrelor Intermediate

 

Description:

 

Ticagrelor is the active pharmaceutical ingredients (API) of branded drug Brillinta, Briliquie and Possia. It was approved in December 3 2010 in Euorpe and in July 2011in USA by FDA . It is marketed by AstraZeneca. Ticagrelor is a platelet aggregation inhibitor and used to prevent thrombotic events such as stroke or heart attack in people with acutate coronary syndrome or myocardial infarction with ST elevation. Ticagrelor is better than clopidogrel for P2Y12 inhibition treatment in patients with NSTE-ACS treated with early invasive strategy and/or coronary stenting according to AHA/ACC Guidelines (09/2014).

 

( 3aR , 4S , 6R , 6aS ) - 6 - Aminotetrahydro - 2 , 2 - dimethyl - 4H - cyclopenta - 1 , 3 - dioxol - 4 - ol CAS No. 155899-66-4 is one of Ticagrelor intermediates. Ticagrelor is protected by some patents in some countries and areas such as USA, Europe and China. We strictly obey the laws and our product is only for R&D purpose. The buyers should determine the patent status and take the risks of patent infringement by themselves.

 

Competitive Advantage: Produced under cGMP conditions, support customers’ registrations.

Contact Details
Asambly Chemicals Co. Ltd.

Contact Person: MAO Xiaolong

Send your inquiry directly to us (0 / 3000)